Oxford Asset Management’s Immune Design Corp. IMDZ Stock Holding History

Oxford Asset Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-270,803	Closed	-$1.58M	–	2124
2019 Q1	$1.58M	Buy	270,803 +134,335	+98%	+$458K	0.03%	698
2018 Q4	$177K	Buy	+136,468	New	+$237K	﹤0.01%	1567
2017 Q4	–	Sell	-32,039	Closed	-$336K	–	2043
2017 Q3	$336K	Sell	32,039 -11,490	-26%	-$113K	0.01%	1316
2017 Q2	$424K	Sell	43,529 -53,699	-55%	-$377K	0.01%	1160
2017 Q1	$661K	Sell	97,228 -5,464	-5%	-$31.6K	0.02%	960
2016 Q4	$565K	Buy	+102,692	New	+$725K	0.02%	567
2016 Q3	–	Sell	-58,083	Closed	-$474K	–	968
2016 Q2	$474K	Sell	58,083 -14,971	-20%	-$187K	0.02%	594
2016 Q1	$950K	Buy	73,054 +16,806	+30%	+$194K	0.03%	513
2015 Q4	$1.17M	Buy	+56,248	New	+$969K	0.03%	498

Oxford Asset Management's IMDZ Position: Q2 2019 in Review

Oxford Asset Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 270,803 shares — an estimated $1.58M sold.

Oxford Asset Management first reported a position in IMDZ in Q4 2015 and held it in 9 quarters. The position peaked at $1.58M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

Oxford Asset Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
Oxford Asset Management sold 270,803 Immune Design Corp. shares in Q2 2019, an estimated $1.58M.
Oxford Asset Management first reported a position in Immune Design Corp. in Q4 2015 and held it in 9 quarters.
Oxford Asset Management's Immune Design Corp. position peaked at $1.58M in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.